Behavioral & Post-Acute Care · Healthcare & Life Sciences
Should you build or buy Substance Use Disorder / Addiction Treatment Platform?
Substance use disorder (SUD) and addiction treatment platforms are specialized EHR and practice management systems for residential, outpatient, and intensive outpatient treatment programs, handling 42 CFR Part 2 consent workflows, ASAM level-of-care documentation, MAT (medication-assisted treatment) protocols, group and individual session notes, and SUD-specific billing and utilization review.
The build-vs-buy decision for SUD treatment platforms turns on how much of the platform value is wrapped up in compliance-specific logic that is costly to replicate and maintain, and how much of the treatment center's competitive position actually depends on the documentation software; the compliance surface area largely shapes the answer.
Build it, buy it, or bridge?
When building makes sense
The build case for SUD treatment software is narrow. The conditions that make it defensible are very large multi-site operators with a dedicated engineering function, or organizations that are building SUD-specific tooling as a commercial product in its own right. Group note generation and billing rule engines are AI-amenable in isolation, and an organization with engineering resources could build those components without too much difficulty. The constraint is the integrated compliance layer: 42 CFR Part 2 consent handling, ASAM level-of-care documentation requirements, and state-specific billing rules are interconnected, and Part 2 in particular has amendment cycles that require ongoing maintenance. That compliance surface area has not been self-built in integrated production form by most independent teams. For a treatment center whose competitive advantage comes from clinical programming and payer contracting — not from documentation software — the strategic return on a custom build is low.
When buying makes sense
Buying SUD treatment software makes sense for the majority of treatment programs. Platforms like Kipu Health, Sunwave, and AZZLY have built 42 CFR Part 2 consent workflows, MAT protocol documentation, and SUD-specific billing into systems that a program can be operational on in weeks. 42 CFR Part 2 is the clearest buy signal: the consent requirements for SUD records are more restrictive than HIPAA, and staying current with Part 2 amendments requires ongoing legal and technical attention that vendors absorb as part of the relationship. ASAM level-of-care documentation and state-specific utilization review formats add to the compliance surface that programs are buying their way out of maintaining. For most treatment centers, the documentation platform is operational infrastructure — the competitive work happens in clinical staff quality, outcome data, and payer contracting.
The desk read
42 CFR Part 2 consent handling and MAT protocol documentation are the two places where SUD treatment platforms like Kipu Health, BestNotes, or AZZLY diverge most sharply from general behavioral health EHRs. Buying earns its keep when a treatment center wants those compliance requirements handled out of the box and doesn't have the engineering capacity to stay current with Part 2 amendments, ASAM level-of-care updates, and state-specific billing rules simultaneously.
The build case is thin here. Group note generation and billing rule engines are AI-amenable in isolation, but the integrated billing and EHR with SUD-specific compliance logic has rarely been self-built in production. Treatment centers compete on clinical programming and payer contracting, not on their documentation platform, which keeps the strategic return on a custom build low. The conditions where building makes sense are narrow: very large multi-site operators with dedicated engineering, or organizations building SUD-specific tooling as a product in its own right.
Frequently asked
What is a substance use disorder / addiction treatment platform?
Substance use disorder (SUD) and addiction treatment platforms are specialized EHR and practice management systems for residential, outpatient, and intensive outpatient treatment programs, handling 42 CFR Part 2 consent workflows, ASAM level-of-care documentation, MAT (medication-assisted treatment) protocols, group and individual session notes, and SUD-specific billing and utilization review.
When does building SUD treatment software make sense?
Building is defensible mainly for very large multi-site operators with dedicated engineering staff, or organizations building SUD tooling as a commercial product. The 42 CFR Part 2 compliance layer and integrated billing create a high baseline complexity that few independent teams have replicated in production.
When does buying SUD treatment software make sense?
Buying makes sense for most treatment programs. Vendors handle 42 CFR Part 2 consent workflows, ASAM level-of-care documentation, and state-specific billing rules — a compliance surface that has ongoing amendment cycles and is difficult to maintain without a dedicated vendor relationship.
What are the main SUD treatment platform vendors?
Representative vendors include Sunwave Health, Ritten, Kipu Health, AZZLY (Rize). B4 Pro scores the full set.
What is 42 CFR Part 2, and why does it matter for SUD software?
42 CFR Part 2 is a federal regulation that governs the confidentiality of substance use disorder treatment records, imposing stricter consent and disclosure requirements than standard HIPAA. SUD-specific platforms are built to handle these workflows natively; using a general behavioral health EHR not designed for Part 2 creates compliance risk.